The North America Minimally Invasive Surgical Instruments Market was valued at USD 9,650 million in 2025 and is estimated to reach USD 17,340 million by 2035, growing at a CAGR of 5.7% from 2024 to 2035. The market is primarily driven by advancements in surgical technologies, increasing adoption of minimally invasive procedures, and growing prevalence of chronic diseases. The U.S. dominates the regional market share owing to robust healthcare infrastructure, high patient awareness, and presence of major industry players such as Medtronic and Stryker.
The economic impact of tariffs on "North America Minimally Invasive Surgical Instruments Market".
Market Growth Drivers
Technological Advancements: Rapid innovation in minimally invasive technologies, including the adoption of robotics, advanced imaging, and precision instruments, is enhancing both patient outcomes and surgical efficiency. For example, Intuitive Surgical's da Vinci Xi Surgical System offers multi-quadrant access and improved visualization, enabling complex procedures with minimal trauma. As hospitals upgrade their operating suites and surgeons seek best-in-class tools, manufacturers are gaining significant opportunities.
Rising Prevalence of Chronic Disorders: The increasing incidence of conditions such as obesity, cancer, and cardiovascular diseases in North America is escalating the demand for minimally invasive surgeries (MIS). Stryker Corporation, for instance, reported growing adoption of its laparoscopic and endoscopic instruments for bariatric and oncologic procedures. The preference for MIS is fueled by shorter recovery times, reduced hospital stays, and lower risk of complications, compelling healthcare facilities to expand their MIS capabilities.
Market Trends
Integration of Artificial Intelligence: Leading companies are increasingly embedding AI and machine learning into surgical platforms to enhance decision-making and workflow optimization. Medtronic has partnered with digital health firms to incorporate real-time AI analytics into its robotics-assisted surgical systems, streamlining workflow and assisting surgeons during intricate procedures. This trend is expected to elevate accuracy, reduce human error, and improve overall surgical outcomes.
Shift Toward Outpatient Settings: The move toward ambulatory surgery centers (ASCs) for minimally invasive surgeries is gaining momentum as patients and providers seek convenience and cost-effectiveness. Zimmer Biomet recently expanded its suite of minimally invasive instruments tailored for outpatient settings, supporting the performance of procedures like arthroscopy and minimally invasive spine surgery outside hospitals. This trend is catalyzing demand for compact, easy-to-use instruments with enhanced safety profiles.
Market Opportunities
Expansion in Untapped Markets: Major players such as Johnson & Johnson are exploring opportunities in Canada and Mexico where adoption of minimally invasive surgery remains lower compared to the U.S. Investments in training, awareness campaigns, and partnerships with local healthcare providers could drive significant growth.
Product Portfolio Diversification: Companies like Olympus Corporation are broadening their product ranges to include advanced visualization tools and energy devices for diverse applications, catering to a wider spectrum of procedures and unlocking new revenue streams.
North America Minimally Invasive Surgical Instruments Market Revenue Forecast (2020-2035)
The chart depicts the consistent upward trajectory of the North American minimally invasive surgical instruments market from 2020 (USD 6,990 million) to 2035 (USD 17,340 million). Beginning with moderate growth between 2020 and 2025, the market accelerates thereafter owing to technological advancements, broader adoption, and rising healthcare expenditures across the region. The period between 2029 and 2035 shows the fastest compounded growth, indicating the strong impact of evolving treatment modalities and expanding patient populations. Investment in R&D and partnerships among leading players is projected to further fuel revenue expansion.
North America Minimally Invasive Surgical Instruments Market Share by Region (2025)
The pie chart illustrates regional market shares in North America for 2025. The United States dominates with 76%, driven by advanced healthcare infrastructure and major manufacturers. Canada follows with 13%, benefitting from growing adoption of new surgical procedures. Mexico holds 7% as government investments in healthcare rise. The combined share of Central American countries and the Caribbean constitutes 2% each, underscoring limited but growing demand. The leadership position of the U.S. is perpetuated by high patient awareness, technological innovation, and favorable reimbursement environments.
Recent Developments (Past 6 Months)
In March 2024, Medtronic announced FDA clearance for its Hugo™ robotic-assisted surgery system in North America. The system facilitates minimally invasive procedures in urology and gynecology and addresses OR workflow bottlenecks with proprietary digital integration and cloud analytics.
In April 2024, Stryker completed the acquisition of Cerus Endovascular, expanding its neurovascular and minimally invasive product portfolio. The merger enables Stryker to strengthen its position in the intervention device market, supporting improved patient outcomes in brain and spine surgeries.
In February 2024, Johnson & Johnson MedTech entered into a strategic collaboration with Microsoft to leverage Azure AI in developing next-generation visualization and navigation solutions for minimally invasive surgery platforms. The initiative focuses on integrating AI-powered guidance to optimize intraoperative decisions and procedural performance.
Press Releases